A Primer on the Surgical Management of Hypertrophic Cardiomyopathy.

IF 5.8 2区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Canadian Journal of Cardiology Pub Date : 2025-04-02 DOI:10.1016/j.cjca.2025.03.029

Ali Fatehi Hassanabad, Madeleine P McKenzie, Ganesh Shanmugam, William Dt Kent

引用次数: 0

Abstract

The management of hypertrophic cardiomyopathy (HCM) has evolved in recent years. Surgery continues to play an important role in the management of patients with HCM. This is particularly relevant for selected patients who prefer to minimize their reliance on medications for symptom control or who remain symptomatic despite receiving optimal or maximal guideline-directed medical therapy. Herein, we provide a succinct primer on the latest literature pertaining to the surgical management of HCM.

查看原文本刊更多论文

肥厚性心肌病的外科治疗初探。

肥厚性心肌病（HCM）的治疗近年来发生了变化。手术在HCM患者的治疗中继续发挥重要作用。对于那些倾向于尽量减少对药物控制症状的依赖，或尽管接受了最佳或最大的指导药物治疗，但仍有症状的患者，这一点尤其重要。在这里，我们提供了一个简洁的入门对最新的文献有关HCM的手术管理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Canadian Journal of Cardiology 医学-心血管系统

CiteScore

9.20

自引率

8.10%

发文量

546

审稿时长

32 days

期刊介绍： The Canadian Journal of Cardiology (CJC) is the official journal of the Canadian Cardiovascular Society (CCS). The CJC is a vehicle for the international dissemination of new knowledge in cardiology and cardiovascular science, particularly serving as the major venue for Canadian cardiovascular medicine.